These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18158723)

  • 1. A simple mechanistic model of deposition of water-soluble aerosol particles in the mouth and throat.
    Mitsakou C; Mitrakos D; Neofytou P; Housiadas C
    J Aerosol Med; 2007; 20(4):519-29. PubMed ID: 18158723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of Particles in Human Mouth-Throat Replicas and a USP Induction Port.
    Cheng YS; Zhou Y; Su WC
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):147-55. PubMed ID: 25137223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-throat.
    Zhang Y; Finlay WH
    J Aerosol Med; 2005; 18(4):460-73. PubMed ID: 16379621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder inhaler aerosol deposition in a model of tracheobronchial airways: Validating CFD predictions with in vitro data.
    Ahookhosh K; Saidi M; Aminfar H; Mohammadpourfard M; Hamishehkar H; Yaqoubi S
    Int J Pharm; 2020 Sep; 587():119599. PubMed ID: 32663586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of generation time on spray aerosol transport and deposition in models of the mouth-throat geometry.
    Worth Longest P; Hindle M; Das Choudhuri S
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):67-83. PubMed ID: 18956949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.
    Hindle M; Longest PW
    Pharm Res; 2010 Sep; 27(9):1800-11. PubMed ID: 20454837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.
    Ferron GA; Upadhyay S; Zimmermann R; Karg E
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):101-19. PubMed ID: 23550602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway.
    Xi J; Longest PW
    Ann Biomed Eng; 2007 Apr; 35(4):560-81. PubMed ID: 17237991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition.
    Schmid O; Bolle I; Harder V; Karg E; Takenaka S; Schulz H; Ferron GA
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):291-307. PubMed ID: 18627243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.
    Tian G; Longest PW; Li X; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):248-65. PubMed ID: 23286828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics.
    Svartengren K; Lindestad P; Svartengren M; Philipson K; Bylin G; Camner P
    Am J Respir Crit Care Med; 1995 Jul; 152(1):32-7. PubMed ID: 7599841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the facial interface on inhalation and deposition of micrometer particles in calm air in a child airway model.
    Xi J; Kim J; Si XA; Su WC; Zhou Y
    Inhal Toxicol; 2014 Jul; 26(8):492-505. PubMed ID: 24987981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental method for measuring aerosol deposition efficiency in the human oral airway.
    Cheng KH; Cheng YS; Yeh HC; Swift DL
    Am Ind Hyg Assoc J; 1997 Mar; 58(3):207-13. PubMed ID: 9075311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation.
    Persons DD; Hess GD; Muller WJ; Scherer PW
    J Appl Physiol (1985); 1987 Sep; 63(3):1195-204. PubMed ID: 3654464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hygroscopic aerosol deposition in the human upper respiratory tract under various thermo-humidity conditions.
    Xi J; Kim J; Si XA; Zhou Y
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1790-805. PubMed ID: 24007434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanims of aerosol particle deposition in the Oro-pharynx under non-steady airflow.
    Sosnowski TR; Moskal A; Gradon L
    Ann Occup Hyg; 2007 Jan; 51(1):19-25. PubMed ID: 17041242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.